Oncología radioterápica
Especialidad
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (13)
2024
-
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis
JNCI Cancer Spectrum, Vol. 8, Núm. 3
-
A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24
BJU International
-
Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
Clinical and Translational Radiation Oncology, Vol. 45
2022
-
Bone health and therapeutic agents in advanced prostate cancer
Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1
-
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study
Neurourology and Urodynamics, Vol. 41, Núm. 8, pp. 1824-1833
-
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
Frontiers in Oncology, Vol. 12
2020
-
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
European urology oncology, Vol. 3, Núm. 4, pp. 455-463
2018
-
Cognitive function in patients on androgen suppression: A prospective, multicentric study
Actas Urologicas Espanolas, Vol. 42, Núm. 2, pp. 114-120
-
GEORCC recommendations on target volumes in radiotherapy for Head Neck Cancer of Unkown Primary
Critical Reviews in Oncology/Hematology, Vol. 130, pp. 51-59
-
Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)
International Journal of Colorectal Disease, Vol. 33, Núm. 2, pp. 241-249
2017
-
Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study
International Journal of Radiation Oncology Biology Physics, Vol. 98, Núm. 3, pp. 590-594
2016
2015
-
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance
Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272